TrialInternational journal of chronic obstructive pulmonary disease2019

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD.

Sanjay Sethi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.